| Device Classification Name |
Complement C3, Antigen, Antiserum, Control
|
| 510(k) Number |
K050665 |
| Device Name |
N ANTISERA TO HUMAN COMPLEMENT FACTORS (C3C, C4) |
| Applicant |
| Dade Behring, Inc. |
| Glasgow Business Community |
| Bldg. 500 M.S. 514; Pox 6101 |
|
Newark,
DE
19714 -6101
|
|
| Applicant Contact |
DONNA A WOLF |
| Correspondent |
| Dade Behring, Inc. |
| Glasgow Business Community |
| Bldg. 500 M.S. 514; Pox 6101 |
|
Newark,
DE
19714 -6101
|
|
| Correspondent Contact |
DONNA A WOLF |
| Regulation Number | 866.5240 |
| Classification Product Code |
|
| Subsequent Product Code |
|
| Date Received | 03/15/2005 |
| Decision Date | 05/02/2005 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Immunology
|
| 510k Review Panel |
Immunology
|
| Summary |
Summary
|
| FDA Review |
Decision Summary
|
| Type |
Traditional
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|